Paul England looks at how much of the success of the life sciences sector in surviving recent economic turmoil is owed to diversification, patenting and collaboration.
A legal toolkit for life sciences companies and their investors providing access to information on:
Patentability of parthenogenic stem cells
Matthew Royle and Paul England provide an update regarding the patentability of parthenogenetically-activated ova and the most recent Advocate General's Opinion as to which cells should be considered "human embryos" under the Biotechnology Directive... read more
Pharmaceutical trade mark confusion
Christopher Benson provides an overview of a recent community trade mark case which demonstrates the importance of assessing the likelihood of confusion between signs for life sciences products from the point of view of consumers from all EU Member States... read more
Receive our monthly newsletter keeping you updated on recent developments and events in the Life Sciences sector...